Abstract
Tetraterpenoids comprise of a large family of C 40 polyene, obtained from plants, fungi and bacteria. Their colouring properties have been employed to use as a natural colorant in the pharmaceutical industries. These exist as an attractive target of research because of their easy availability and plentiful health benefits in cardiovascular diseases, cancer, age related degenerative diseases, macular degeneration, antiatherosclerotic, anti-inflammatory, immunomodulatory properties and in HIV infection, probably due to their antioxidant properties. Formulating carotenoids in a particular dosage form is a big challenge as they possess some limitations like chemical unstability, poor bioavailability, less solubility and quick release. Due to this, numerous nanoencapsulation techniques have been developed till now to maintain their original properties. This review will highlight the phytochemical and pharmacological update on tetraterpenoids and their formulations.
Keywords: Carotenoids, lycopene, carotene, xanthophylls, nano-formulations, tetraterpenoids.
Graphical Abstract
The Natural Products Journal
Title:Phytochemistry and Pharmacological Update on Tetraterpenoids
Volume: 11 Issue: 5
Author(s): Sapna Kumari*, Anju Goyal and Madhukar Garg
Affiliation:
- Chitkara College of Pharmacy, Chitkara University, Punjab,India
Keywords: Carotenoids, lycopene, carotene, xanthophylls, nano-formulations, tetraterpenoids.
Abstract: Tetraterpenoids comprise of a large family of C 40 polyene, obtained from plants, fungi and bacteria. Their colouring properties have been employed to use as a natural colorant in the pharmaceutical industries. These exist as an attractive target of research because of their easy availability and plentiful health benefits in cardiovascular diseases, cancer, age related degenerative diseases, macular degeneration, antiatherosclerotic, anti-inflammatory, immunomodulatory properties and in HIV infection, probably due to their antioxidant properties. Formulating carotenoids in a particular dosage form is a big challenge as they possess some limitations like chemical unstability, poor bioavailability, less solubility and quick release. Due to this, numerous nanoencapsulation techniques have been developed till now to maintain their original properties. This review will highlight the phytochemical and pharmacological update on tetraterpenoids and their formulations.
Export Options
About this article
Cite this article as:
Kumari Sapna *, Goyal Anju and Garg Madhukar , Phytochemistry and Pharmacological Update on Tetraterpenoids, The Natural Products Journal 2021; 11 (5) . https://dx.doi.org/10.2174/2210315510999200806154609
DOI https://dx.doi.org/10.2174/2210315510999200806154609 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Blood Pressure Control in Cardiovascular Prevention
Current Pharmaceutical Design Analysis of the Salivary Microbiome in the Periodontal Disease Patients with Hypertension and Non-hypertension
Current Bioinformatics Family History and Preclinical Atherosclerosis
Current Hypertension Reviews A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal
Endocrine, Metabolic & Immune Disorders - Drug Targets Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms
Current Hypertension Reviews Non-dipping Status in Arterial Hypertension: An Overview
Current Vascular Pharmacology Programmed Cell Death after Intracerebral Hemorrhage
Current Neuropharmacology Atrial Fibrillation and Hypertension: “Quo Vadis”
Current Hypertension Reviews Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
Current Pharmaceutical Design Alcohol and the Cardiovascular System: A Double-Edged Sword
Current Pharmaceutical Design The Effect of Polyphenol Consumption on Blood Pressure
Mini-Reviews in Medicinal Chemistry Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Understanding eNOS for Pharmacological Modulation of Endothelial Function: A Translational View
Current Pharmaceutical Design Cyclooxygenase-2 Inhibitors: A Painful Lesson
Cardiovascular & Hematological Disorders-Drug Targets The Effect of Antihypertensive Agents on Insulin Sensitivity, Lipids and Haemostasis
Current Vascular Pharmacology Microparticles as Biomarkers of Vascular Dysfunction in Metabolic Syndrome and its Individual Components
Current Vascular Pharmacology High Glucose-Mediated Imbalance of Nitric Oxide Synthase and Dimethylarginine Dimethylaminohydrolase Expression in Endothelial Cells
Current Neurovascular Research Intestinal Barrier Dysfunction Participates in the Pathophysiology of Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Effect of Soy Isoflavone Supplementation on Endothelial Dysfunction and Oxidative Stress in Equol-Producing Postmenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Statin Drugs, Metabolic Pathways, and Asthma: A Therapeutic Opportunity Needing Further Research
Drug Metabolism Letters